IP Library › Granted Patent US 10,005,770
Granted Patent B2
US 10,005,770 · App. 15/216,501 · Granted Jun 26, 2018

Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine

Inventors: Junli Chen (Shanghai, CN); Yi Ren (Shanghai, CN); Jin She (Shanghai, CN); Lin Wang (Shanghai, CN); Jianhua Yu (Shanghai, CN); Guocai Zhang (Shanghai, CN)
Assignee: Hoffmann-La Roche Inc.
C07D417/14C07D305/06C07D305/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,005,770
App. No.
15/216,501
Granted
Jun 26, 2018
Kind
B2
Abstract

The present invention relates to a novel process for the preparation of a compound of the formula (I): and pharmaceutically acceptable acid addition salts thereof, which is useful for prophylaxis and treatment of respiratory syncytial virus (RSV) infection in mammal or human being.

Claims (48)

1. Process for the preparation of a compound of the formula (I):

or pharmaceutically acceptable addition salts thereof,

comprising the following steps:

step a) oxidation of [3-(bromomethyl)oxetan-3-yl]methanol of formula (II) to form a compound of formula (III)

step b) conversion of carboxy group of a compound of formula (III) to carbamate to form a compound of formula (IV)

wherein R is C 1-6 alkyl, C 1-6 alkoxyphenyl-C x H 2x — or phenyl-C x H 2x —, wherein x is 1-6;

step c) amination of a compound of formula (IV) to form a compound of formula (V)

wherein R is as defined above;

step d) salt formation of a compound of formula (V) with an acid to form a compound of formula (VI)

wherein R is as defined above;

step e) substitution reaction of a compound of formula (VI) with a compound of formula (IX)

to give a compound of formula (VII)

wherein R is as defined above;

step f) substitution reaction of a compound of formula (VII) with a compound of formula (X)

to give a compound of formula (VIII)

wherein R is as defined above;

step g) comprises deprotection of a compound of formula (VIII) to give a compound of formula (I)

and if necessary, form a pharmaceutically acceptable addition salt.

2. A process according to claim 1 , wherein R is tert-butyl, 1,1-dimethylpropyl, benzyl or 4-methoxyphenylmethyl.

3. A process according to claim 1 , wherein step a) is performed with an oxidant at a reaction temperature range between 0° C. and 100° C.

4. A process according to claim 1 , wherein step a) is performed in a solvent comprising water, acetonitrile, dichloromethane, ethyl acetate or isopropyl acetate; or a co-solvent which is a mixture of two or more kinds of solvents comprising water, acetonitrile, dichloromethane, ethyl acetate or isopropyl acetate.

5. A process according to claim 3 , wherein the oxidant comprises sodium hypochlorite, potassium permanganate, 2,2,6,6-tetramethylpiperidinooxy or pyridinium chlorochromate; or a co-oxidant which is a mixture of two or more kinds of oxidants comprising sodium hypochlorite, potassium permanganate, 2,2,6,6-tetramethylpiperidinooxy or pyridinium chlorochromate.

6. A process according to claim 1 , wherein step b) is performed with an azide reagent and a base in an organic solvent and followed by adding an alcohol at temperature range of 0° C. and 100° C.

7. A process according to claim 6 , wherein the azide reagent used in step b) is diphenylphosphoryl azide.

8. A process according to claim 6 , wherein the base used in step b) is triethylamine, diisopropylethylamine or 4-methyl morpholine.

9. A process according to claim 6 , wherein the solvent used in step b) is acetonitrile, toluene, chlorobenzene or dichloromethane.

10. A process according to claim 6 , wherein the alcohol used in step b) is tert-butanol, 2-methyl-2-butanol, benzyl alcohol or 4-methoxyphenylmethanol.

11. A process according to claim 1 , wherein step c) is performed with an amination agent, at reaction temperature range of 0° C. and 60° C.

12. A process according to claim 11 , wherein the amination agent used in step c) is liquid ammonia.

13. A process according to claim 1 , wherein step d) is performed in a solvent with an organic or inorganic acid at a temperature range of 0° C. and 60° C.

14. A process according to claim 13 , wherein the solvent used in step d) is tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, ethylacetate or methyl tert-butyl ether.

15. A process according to claim 13 , wherein the acid used in step d) is hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, acetic acid, L-tartaric acid, citric acid, L-lactic acid, maleic acid, fumaric acid, succinic acid, methanesulfonic acid, benzenesulfonic acid, benzoic acid, p-toluenesulfonic acid, oxalic acid, p-nitrobenzoic acid, salicylic acid or 4-chlorobenzoic acid.

16. A process according to claim 1 , wherein step e) is performed in tetrahydrofuran at reaction temperature range between 10° C. and 30° C.

17. A process according to claim 1 , wherein step f) is performed in an organic solvent with acid catalyst in temperature range between 0° C. and 100° C.

18. A process according to claim 1 , wherein step g) is performed in an organic solvent with acid in temperature range between 0° C. and 100° C.

19. A process according to claim 3 , wherein step a) is performed with an oxidant at a reaction temperature range between 15° C. to 25° C.

20. A process according to claim 4 , wherein the solvent is a co-solvent of water and acetonitrile.

21. A process according to claim 5 , wherein the oxidant is a co-oxidant of 2,2,6,6-tetramethylpiperidinooxy and sodium hypochlorite.

22. A process according to claim 6 , wherein step b) is performed with an azide reagent and a base in an organic solvent and followed by adding an alcohol at temperature of 80° C.

23. A process according to claim 6 , wherein the base used in step b) is 4-methylmorpholine.

24. A process according to claim 6 , wherein the solvent used in step b) is toluene.

25. A process according to claim 6 , wherein the alcohol used in step b) is 4-methoxyphenylmethanol.

26. A process according to claim 1 , wherein step c) is performed with an amination agent, at reaction temperature range of 25° C. and 30° C.

27. A process according to claim 13 , wherein step d) is performed in a solvent with an organic or inorganic acid at a temperature range of 15° C. and 25° C.

28. A process according to claim 14 , wherein the solvent used in step d) is methyl tert-butyl ether.

29. A process according to claim 13 , wherein the acid used in step d) is 4-chlorobenzoic acid.

30. A process according to claim 17 , wherein step f) is performed in an organic solvent with acid catalyst in temperature range between 60° C. and 80° C.

31. A process according to claim 1 , wherein step g) is performed in an organic solvent with acid in temperature range between 10° C. and 40° C.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: CHEN, JUNLI; REN, YI; SHE, JIN; WANG, LIN; YU, JIANHUA; ZHANG, GUOCAI
To: ROCHE R&D CENTER (CHINA) LTD.
Reel/Frame 040310/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: ROCHE R&D CENTER (CHINA) LTD.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 040310/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 040311/0032 →
Continuity (2)
Continuation PCTEP2015051066 · Jan 21, 2015
Related Publication 20160326160A1 · Nov 10, 2016